Type Whole antibody Target endotoxin CAS Number 138661-01-5 | Source Human ATC code J06BC01 (WHO) | |
AHFS/Drugs.com International Drug Names | ||
How to pronounce nebacumab
Nebacumab is a human monoclonal antibody developed for the treatment of sepsis. It has been withdrawn in 1993 because it failed to reduce mortality in clinical trials.
References
Nebacumab Wikipedia(Text) CC BY-SA